Stem cell research trial hinges on proper implementation
              By Jeff Shuttleworth, Bay City News Service 
              February 27, 2006
              HAYWARD (BCN) -- Attorneys clashed today over the constitutionality 
                of California's $3 billion voter-approved stem cell research program. 
              In opening statements in a non-jury trial in Alameda County Superior 
                Court, attorneys for taxpayer organizations and a bioethics group 
                alleged that the lack of direct state control over the California 
                Institute of Regenerative Medicine's finances violates the state 
                constitution. 
              But state Deputy Attorney General Tamar Pachter, who is defending 
                the institution, said Proposition 71, which was approved by 59 
                percent of California voters who went to the polls in November 
                2004, is being implemented in accordance with the state constitution 
                and state statutes. 
              Pachter accused the attorneys who are trying to block the initiative 
                of engaging in "a tortured interpretation of the constitution" 
                and said "control mechanisms are working as intended" 
                to ensure that the program is operating as intended. 
              Proposition 71 calls for allocating $300 million a year in research 
                grants for 10 years. 
              It created the California Institute of Regenerative Medicine, 
                which is based in San Francisco, and its 29-member governing body, 
                the Independent Citizens' Oversight Committee. 
              Robert Klein, a Palo Alto real estate developer who spearheaded 
                the ballot drive, chairs the committee. 
              No grant money has been handed out so far because of legal challenges 
                by the People's Advocate and National Tax Limitation Foundation 
                and the California Family Bioethics Council. 
              The suits have been consolidated into a single trial before Judge 
                Bonnie Sabraw, who has set aside two weeks for the case. But trial 
                participants say it appears that very few witnesses will be called 
                and that the case may conclude later this week. 
              Backers put Proposition 71 on the ballot as a response to the 
                Bush Administration's decision to cap federal funding for stem 
                cell research at about $25 million annually and impose strict 
                research guidelines that scientists say limit advances. 
              President Bush and many other social conservatives oppose some 
                stem cell programs because human embryos are destroyed during 
                research. 
              Supporters of embryonic stem cell research say embryonic stem 
                cells promise more versatility than adult stem cells and could 
                help people with spinal cord injuries and diseases that include 
                childhood diabetes, Alzheimer's and Parkinson's. 
              Five people in wheelchairs attended the opening statements today, 
                as did family members of people with various disabilities and 
                illnesses. 
              David Llewellyn, the attorney for the California Family Bioethics 
                Council, told reporters during a break in the trial today that 
                the groups who are fighting Proposition 71 in court support adult 
                stem cell research, and that embryonic stem cell research has 
                been unsuccessful. 
              He said, "It's a shame that this immense amount of money 
                can't be spent for a certain return." 
              In court, Llewellyn told Sabraw that at a meeting last September, 
                Ed Penhoet, CIRM's vice chair, illustrated the uncertainty of 
                the program's financial payoff by stating that it's impossible 
                to know the value of technology that hasn't been invented yet. 
              Llewellyn also alleged that many oversight committee members 
                have conflicts of interest because they have investments in biotech 
                companies that aim to profit from stem cell research or are affiliated 
                with universities and other facilities that hope to get funding 
                for such research. 
              But Pachter said committee members are "a talented, dedicated 
                group of people who are not on it for personal or institutional 
                gain." 
              Pachter said "members are experts in fields that are critical 
                to  
                the mission" of the stem cell program.  
              Copyright © 2006 by Bay City News, Inc. -- Republication, 
                Rebroadcast or any other Reuse without the express written consent 
                of Bay City News, Inc. is prohibited. 
              #### 
               
                
                
               
              
              
             |